文献速递肿瘤 PET/CT放射性药物与辐射防护

COVID-19肺炎晚期PET/CT表现:PSMA摄取高于FDG的病例对比

Late PET/CT Findings of COVID-19 Pneumonia With 2 Different Radiopharmaceuticals in a Patient: PSMA Avidity Higher Than FDGs.
PubMed 文献 · Clin Nucl Med · 2021-01-01

本文对比一例67岁前列腺癌合并恶性黑色素瘤患者感染COVID-19肺炎3个月后的68Ga-PSMA与18F-FDG PET/CT表现。68Ga-PSMA PET/CT显示肺部磨玻璃影PSMA摄取明显增高,而18F-FDG PET/CT在相同区域FDG摄取极少。提示COVID-19肺炎中期肺PSMA摄取较FDG更强烈,可能有助于理解疾病愈合期。

要点

  • COVID-19肺炎3个月后肺部磨玻璃影PSMA摄取明显增高
  • 相同区域FDG摄取极少,PSMA与FDG表现不一致
  • 该现象可能有助于理解COVID-19肺炎的愈合期

核心结论

  • COVID-19肺炎中期肺部PSMA摄取比FDG更强烈,可能有助于更好理解疾病的愈合阶段。

研究设计与样本

  • 病例报告:一例67岁前列腺癌合并恶性黑色素瘤患者,3个月前患COVID-19肺炎并在重症监护室治疗13天,对比行68Ga-PSMA与18F-FDG PET/CT。

主要发现

  • 68Ga-PSMA PET/CT显示肺部磨玻璃影PSMA摄取明显增高。
  • 18F-FDG PET/CT在相同区域FDG摄取极少。

临床怎么用

  • COVID-19肺炎后中期行PSMA PET/CT时,肺部磨玻璃影的PSMA高摄取可能反映愈合期改变,需与肿瘤转移鉴别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We present the 68Ga-PSMA and 18F-FDG PET/CT findings comparatively of a 67-year-old prostate cancer and malignant melanoma patient who had COVID-19 pneumonia 3 months ago. In 68Ga-PSMA PET/CT, ground-glass opacities showing markedly increased PSMA uptake were observed in the patient's lungs. It was learned that the patient had COVID-19 pneumonia 3 months ago and was treated in the intensive care unit for 13 days. In 18F-FDG PET/CT, FDG uptake was minimal in the same areas. In the midterm period after COVID-19 pneumonia, lung PSMA uptake is more intense than FDG, which may help better understand the disease's healing phase.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Şahin Ö, Kaya B, Aydın Z, et al. Late PET/CT Findings of COVID-19 Pneumonia With 2 Different Radiopharmaceuticals in a Patient: PSMA Avidity Higher Than FDGs. Clin Nucl Med. 2021. PMID: 34477606. doi:10.1097/RLU.0000000000003720

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。